<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33065963</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>20</Issue><PubDate><Year>2020</Year><Month>Oct</Month><Day>13</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>ALS-Related Mutant SOD1 Aggregates Interfere with Mitophagy by Sequestering the Autophagy Receptor Optineurin.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">7525</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms21207525</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the progressive demise of motor neurons. One of the causes of familial ALS is the mutation of the gene encoding superoxide dismutase 1 (SOD1), which leads to abnormal protein aggregates. How SOD1 aggregation drives ALS is still poorly understood. Recently, ALS pathogenesis has been functionally implicated in mitophagy, specifically the clearance of damaged mitochondria. Here, to understand this mechanism, we investigated the relationship between the mitophagy receptor optineurin and SOD1 aggregates. We found that mutant SOD1 (mSOD1) proteins associate with and then sequester optineurin, which is required to form the mitophagosomes, to aggregates in N2a cells. Optineurin recruitment into mSOD1 aggregates resulted in a reduced mitophagy flux. Furthermore, we observed that an exogenous augmentation of optineurin alleviated the cellular cytotoxicity induced by mSOD1. Taken together, these studies demonstrate that ALS-linked mutations in SOD1 interfere with the mitophagy process through optineurin sequestration, suggesting that the accumulation of damaged mitochondria may play a crucial role in the pathophysiological mechanisms contributing to ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tak</LastName><ForeName>Yeong Jin</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Division of Life Sciences, Korea University, Seoul 02841, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Ju-Hwang</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Division of Life Sciences, Korea University, Seoul 02841, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rhim</LastName><ForeName>Hyangshuk</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biomedicine and Health Sciences, College of Medicine, The Catholic University of Korea, Seoul 137-701, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Life Sciences, College of Medicine, The Catholic University of Korea, Seoul 137-701, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Seongman</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Life Sciences, Korea University, Seoul 02841, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2018R1A2B6001440</GrantID><Agency>National Research Foundation of Korea</Agency><Country/></Grant><Grant><GrantID>2015R1A4A1041919</GrantID><Agency>National Research Foundation of Korea</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018797">Cell Cycle Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D026901">Membrane Transport Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C501288">Optn protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="C000606291">Sod1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018797" MajorTopicYN="N">Cell Cycle Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D026901" MajorTopicYN="N">Membrane Transport Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063306" MajorTopicYN="Y">Mitophagy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066263" MajorTopicYN="N">Protein Aggregation, Pathological</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">mitophagy</Keyword><Keyword MajorTopicYN="N">optineurin (OPTN)</Keyword><Keyword MajorTopicYN="N">superoxide dismutase 1 (SOD1)</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>17</Day><Hour>1</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33065963</ArticleId><ArticleId IdType="pmc">PMC7590160</ArticleId><ArticleId IdType="doi">10.3390/ijms21207525</ArticleId><ArticleId IdType="pii">ijms21207525</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Taylor J.P., Brown R.H., Jr., Cleveland D.W. Decoding ALS: From genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Boillee S., Vande Velde C., Cleveland D.W. ALS: A disease of motor neurons and their nonneuronal neighbors. Neuron. 2006;52:39&#x2013;59. doi: 10.1016/j.neuron.2006.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.09.018</ArticleId><ArticleId IdType="pubmed">17015226</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., van den Berg L.H., Kiernan M.C. Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat. Rev. Neurol. 2011;7:639. doi: 10.1038/nrneurol.2011.153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.153</ArticleId><ArticleId IdType="pubmed">21989247</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R., Hardiman O., Benatar M., Brooks B.R., Chio A., de Carvalho M., Ince P.G., Lin C., Miller R.G., Mitsumoto H., et al. Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol. 2013;12:310&#x2013;322. doi: 10.1016/S1474-4422(13)70036-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(13)70036-X</ArticleId><ArticleId IdType="pmc">PMC4565161</ArticleId><ArticleId IdType="pubmed">23415570</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinelli P., Brown R.H. Molecular biology of amyotrophic lateral sclerosis: Insights from genetics. Nat. Rev. Neurosci. 2006;7:710&#x2013;723. doi: 10.1038/nrn1971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1971</ArticleId><ArticleId IdType="pubmed">16924260</ArticleId></ArticleIdList></Reference><Reference><Citation>Paez-Colasante X., Figueroa-Romero C., Sakowski S.A., Goutman S.A., Feldman E.L. Amyotrophic lateral sclerosis: Mechanisms and therapeutics in the epigenomic era. Nat. Rev. Neurosci. 2015;11:266&#x2013;279. doi: 10.1038/nrneurol.2015.57.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2015.57</ArticleId><ArticleId IdType="pubmed">25896087</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook C., Petrucelli L. Genetic convergence brings clarity to the enigmatic red line in ALS. Neuron. 2019;101:1057&#x2013;1069. doi: 10.1016/j.neuron.2019.02.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.02.032</ArticleId><ArticleId IdType="pubmed">30897357</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan M.C., Vucic S., Cheah B.C., Turner M.R., Eisen A., Hardiman O., Burrell J.R., Zoing M.C. Amyotrophic lateral sclerosis. Lancet. 2011;377:942&#x2013;955. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Chio A., Traynor B.J. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O&#x2019;Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Valentine J.S., Doucette P.A., Zittin Potter S. Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Ann. Rev. Biochem. 2005;74:563&#x2013;593. doi: 10.1146/annurev.biochem.72.121801.161647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.biochem.72.121801.161647</ArticleId><ArticleId IdType="pubmed">15952898</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakhit R., Cunningham P., Furtos-Matei A., Dahan S., Qi X.F., Crow J.P., Cashman N.R., Kondejewski L.H., Chakrabartty A. Oxidation-induced misfolding and aggregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis. J. Biol. Chem. 2002;277:47551&#x2013;47556. doi: 10.1074/jbc.M207356200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M207356200</ArticleId><ArticleId IdType="pubmed">12356748</ArticleId></ArticleIdList></Reference><Reference><Citation>Munch C., Bertolotti A. Exposure of hydrophobic surfaces initiates aggregation of diverse ALS-causing superoxide dismutase-1 mutants. J. Mol. Biol. 2010;399:512&#x2013;525. doi: 10.1016/j.jmb.2010.04.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2010.04.019</ArticleId><ArticleId IdType="pmc">PMC2927901</ArticleId><ArticleId IdType="pubmed">20399791</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassall K.A., Stubbs H.R., Primmer H.A., Tong M.S., Sullivan S.M., Sobering R., Srinivasan S., Briere L.A., Dunn S.D., Colon W., et al. Decreased stability and increased formation of soluble aggregates by immature superoxide dismutase do not account for disease severity in ALS. Proc. Natl. Acad. Sci. USA. 2011;108:2210&#x2013;2215. doi: 10.1073/pnas.0913021108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0913021108</ArticleId><ArticleId IdType="pmc">PMC3038722</ArticleId><ArticleId IdType="pubmed">21257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Banci L., Bertini I., Boca M., Calderone V., Cantini F., Girotto S., Vieru M. Structural and dynamic aspects related to oligomerization of apo SOD1 and its mutants. Proc. Natl. Acad. Sci. USA. 2009;106:6980&#x2013;6985. doi: 10.1073/pnas.0809845106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0809845106</ArticleId><ArticleId IdType="pmc">PMC2678485</ArticleId><ArticleId IdType="pubmed">19369197</ArticleId></ArticleIdList></Reference><Reference><Citation>Urushitani M., Kurisu J., Tsukita K., Takahashi R. Proteasomal inhibition by misfolded mutant superoxide dismutase 1 induces selective motor neuron death in familial amyotrophic lateral sclerosis. J. Neurochem. 2002;83:1030&#x2013;1042. doi: 10.1046/j.1471-4159.2002.01211.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2002.01211.x</ArticleId><ArticleId IdType="pubmed">12437574</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J.H., Jang H.R., Lee I.Y., Oh H.K., Choi E.J., Rhim H., Kang S. Amyotrophic lateral sclerosis-related mutant superoxide dismutase 1 aggregates inhibit 14&#x2013;3&#x2013;3-mediated cell survival by sequestration into the JUNQ compartment. Hum. Mol. Genet. 2017;26:3615&#x2013;3629. doi: 10.1093/hmg/ddx250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx250</ArticleId><ArticleId IdType="pubmed">28666328</ArticleId></ArticleIdList></Reference><Reference><Citation>Vande Velde C., Miller T.M., Cashman N.R., Cleveland D.W. Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria. Proc. Natl. Acad. Sci. USA. 2008;105:4022&#x2013;4027. doi: 10.1073/pnas.0712209105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0712209105</ArticleId><ArticleId IdType="pmc">PMC2268797</ArticleId><ArticleId IdType="pubmed">18296640</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva H., Polymenidou M., Cleveland D.W. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell Biol. 2009;187:761&#x2013;772. doi: 10.1083/jcb.200908164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200908164</ArticleId><ArticleId IdType="pmc">PMC2806318</ArticleId><ArticleId IdType="pubmed">19951898</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.P., Hardy J., Fischbeck K.H. Toxic proteins in neurodegenerative disease. Science. 2002;296:1991&#x2013;1995. doi: 10.1126/science.1067122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1067122</ArticleId><ArticleId IdType="pubmed">12065827</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto C. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat. Rev. Neurosci. 2003;4:49&#x2013;60. doi: 10.1038/nrn1007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1007</ArticleId><ArticleId IdType="pubmed">12511861</ArticleId></ArticleIdList></Reference><Reference><Citation>Lashuel H.A., Overk C.R., Oueslati A., Masliah E. The many faces of alpha-synuclein: From structure and toxicity to therapeutic target. Nat. Rev. Neurosci. 2013;14:38&#x2013;48. doi: 10.1038/nrn3406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3406</ArticleId><ArticleId IdType="pmc">PMC4295774</ArticleId><ArticleId IdType="pubmed">23254192</ArticleId></ArticleIdList></Reference><Reference><Citation>Haass C., Selkoe D.J. Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer&#x2019;s amyloid &#x3b2;-peptide. Nat. Rev. Mol. Cell Biol. 2007;8:101&#x2013;112. doi: 10.1038/nrm2101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm2101</ArticleId><ArticleId IdType="pubmed">17245412</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal K., Alonso Adel C., Chen S., Chohan M.O., El-Akkad E., Gong C.X., Khatoon S., Li B., Liu F., Rahman A., et al. Tau pathology in Alzheimer disease and other tauopathies. Biochim. Biophys. Acta. 2005;1739:198&#x2013;210. doi: 10.1016/j.bbadis.2004.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2004.09.008</ArticleId><ArticleId IdType="pubmed">15615638</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies S.W., Turmaine M., Cozens B.A., DiFiglia M., Sharp A.H., Ross C.A., Scherzinger E., Wanker E.E., Mangiarini L., Bates G.P. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell. 1997;90:537&#x2013;548. doi: 10.1016/S0092-8674(00)80513-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)80513-9</ArticleId><ArticleId IdType="pubmed">9267033</ArticleId></ArticleIdList></Reference><Reference><Citation>Blokhuis A.M., Groen E.J., Koppers M., van den Berg L.H., Pasterkamp R.J. Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol. 2013;125:777&#x2013;794. doi: 10.1007/s00401-013-1125-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1125-6</ArticleId><ArticleId IdType="pmc">PMC3661910</ArticleId><ArticleId IdType="pubmed">23673820</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundaramoorthy V., Walker A.K., Tan V., Fifita J.A., McCann E.P., Williams K.L., Blair I.P., Guillemin G.J., Farg M.A., Atkin J.D. Defects in optineurin-and myosin VI-mediated cellular trafficking in amyotrophic lateral sclerosis. Hum. Mol. Genet. 2015;24:3830&#x2013;3846. doi: 10.1093/hmg/ddv126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv126</ArticleId><ArticleId IdType="pubmed">25859013</ArticleId></ArticleIdList></Reference><Reference><Citation>Akizuki M., Yamashita H., Uemura K., Maruyama H., Kawakami H., Ito H., Takahashi R. Optineurin suppression causes neuronal cell death via NF-kappaB pathway. J. Neurochem. 2013;126:699&#x2013;704. doi: 10.1111/jnc.12326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.12326</ArticleId><ArticleId IdType="pubmed">23721573</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan T.A., Tumbarello D.A. Optineurin: A coordinator of membrane-associated cargo trafficking and autophagy. Front. Immunol. 2018;9:1024. doi: 10.3389/fimmu.2018.01024.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01024</ArticleId><ArticleId IdType="pmc">PMC5962687</ArticleId><ArticleId IdType="pubmed">29867991</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruyama H., Morino H., Ito H., Izumi Y., Kato H., Watanabe Y., Kinoshita Y., Kamada M., Nodera H., Suzuki H., et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature. 2010;465:223&#x2013;226. doi: 10.1038/nature08971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08971</ArticleId><ArticleId IdType="pubmed">20428114</ArticleId></ArticleIdList></Reference><Reference><Citation>Wild P., Farhan H., McEwan D.G., Wagner S., Rogov V.V., Brady N.R., Richter B., Korac J., Waidmann O., Choudhary C., et al. Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science. 2011;333:228&#x2013;233. doi: 10.1126/science.1205405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1205405</ArticleId><ArticleId IdType="pmc">PMC3714538</ArticleId><ArticleId IdType="pubmed">21617041</ArticleId></ArticleIdList></Reference><Reference><Citation>Korac J., Schaeffer V., Kovacevic I., Clement A.M., Jungblut B., Behl C., Terzic J., Dikic I. Ubiquitin-independent function of optineurin in autophagic clearance of protein aggregates. J. Cell Sci. 2013;126:580&#x2013;592. doi: 10.1242/jcs.114926.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.114926</ArticleId><ArticleId IdType="pmc">PMC3654196</ArticleId><ArticleId IdType="pubmed">23178947</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong Y.C., Holzbaur E.L. Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation. Proc. Natl. Acad. Sci. USA. 2014;111:E4439&#x2013;E4448. doi: 10.1073/pnas.1405752111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1405752111</ArticleId><ArticleId IdType="pmc">PMC4210283</ArticleId><ArticleId IdType="pubmed">25294927</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodolfo C., Campello S., Cecconi F. Mitophagy in neurodegenerative diseases. Neurochem. Int. 2018;117:156&#x2013;166. doi: 10.1016/j.neuint.2017.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2017.08.004</ArticleId><ArticleId IdType="pubmed">28797885</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore A.S., Holzbaur E.L. Dynamic recruitment and activation of ALS-associated TBK1 with its target optineurin are required for efficient mitophagy. Proc. Natl. Acad. Sci. USA. 2016;113:E3349&#x2013;E3358. doi: 10.1073/pnas.1523810113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1523810113</ArticleId><ArticleId IdType="pmc">PMC4914160</ArticleId><ArticleId IdType="pubmed">27247382</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishitoh H., Kadowaki H., Nagai A., Maruyama T., Yokota T., Fukutomi H., Noguchi T., Matsuzawa A., Takeda K., Ichijo H. ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1. Genet. Dev. 2008;22:1451&#x2013;1464. doi: 10.1101/gad.1640108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1640108</ArticleId><ArticleId IdType="pmc">PMC2418582</ArticleId><ArticleId IdType="pubmed">18519638</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedrini S., Sau D., Guareschi S., Bogush M., Brown R.H., Jr., Naniche N., Kia A., Trotti D., Pasinelli P. ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2. Hum. Mol. Genet. 2010;19:2974&#x2013;2986. doi: 10.1093/hmg/ddq202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq202</ArticleId><ArticleId IdType="pmc">PMC2901139</ArticleId><ArticleId IdType="pubmed">20460269</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G., Berk M. The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders. BMC Med. 2015;13:68. doi: 10.1186/s12916-015-0310-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-015-0310-y</ArticleId><ArticleId IdType="pmc">PMC4382850</ArticleId><ArticleId IdType="pubmed">25889215</ArticleId></ArticleIdList></Reference><Reference><Citation>Leadsham J.E., Sanders G., Giannaki S., Bastow E.L., Hutton R., Naeimi W.R., Breitenbach M., Gourlay C.W. Loss of cytochrome c oxidase promotes RAS-dependent ROS production from the ER resident NADPH oxidase, Yno1p, in yeast. Cell Metab. 2013;18:279&#x2013;286. doi: 10.1016/j.cmet.2013.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2013.07.005</ArticleId><ArticleId IdType="pubmed">23931758</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans C.S., Holzbaur E.L.F. Autophagy and mitophagy in ALS. Neurobiol. Dis. 2019;122:35&#x2013;40. doi: 10.1016/j.nbd.2018.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.07.005</ArticleId><ArticleId IdType="pmc">PMC6366665</ArticleId><ArticleId IdType="pubmed">29981842</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Lillo C., Jonsson P.A., Vande Velde C., Ward C.M., Miller T.M., Subramaniam J.R., Rothstein J.D., Marklund S., Andersen P.M., et al. Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron. 2004;43:5&#x2013;17. doi: 10.1016/j.neuron.2004.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.06.016</ArticleId><ArticleId IdType="pubmed">15233913</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickles S., Destroismaisons L., Peyrard S.L., Cadot S., Rouleau G.A., Brown R.H., Jr., Julien J.P., Arbour N., Vande Velde C. Mitochondrial damage revealed by immunoselection for ALS-linked misfolded SOD1. Hum. Mol. Genet. 2013;22:3947&#x2013;3959. doi: 10.1093/hmg/ddt249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt249</ArticleId><ArticleId IdType="pmc">PMC5052069</ArticleId><ArticleId IdType="pubmed">23736301</ArticleId></ArticleIdList></Reference><Reference><Citation>Tafuri F., Ronchi D., Magri F., Comi G.P., Corti S. SOD1 misplacing and mitochondrial dysfunction in amyotrophic lateral sclerosis pathogenesis. Front. Cell. Neurosci. 2015;9:336. doi: 10.3389/fncel.2015.00336.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00336</ArticleId><ArticleId IdType="pmc">PMC4548205</ArticleId><ArticleId IdType="pubmed">26379505</ArticleId></ArticleIdList></Reference><Reference><Citation>Osawa T., Mizuno Y., Fujita Y., Takatama M., Nakazato Y., Okamoto K. Optineurin in neurodegenerative diseases. Neuropathol. Off. J. Jpn. Soc. Neuropathol. 2011;31:569&#x2013;574. doi: 10.1111/j.1440-1789.2011.01199.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1789.2011.01199.x</ArticleId><ArticleId IdType="pubmed">21284751</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu P.H., Raju P., Robinson K.A., Gurney M.E., Trojanowski J.Q., Lee V.M. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc. Natl. Acad. Sci. USA. 1996;93:3155&#x2013;3160. doi: 10.1073/pnas.93.7.3155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.93.7.3155</ArticleId><ArticleId IdType="pmc">PMC39778</ArticleId><ArticleId IdType="pubmed">8610185</ArticleId></ArticleIdList></Reference><Reference><Citation>Johri A., Beal M.F. Mitochondrial dysfunction in neurodegenerative diseases. J. Pharmacol. Exp. Ther. 2012;342:619&#x2013;630. doi: 10.1124/jpet.112.192138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.112.192138</ArticleId><ArticleId IdType="pmc">PMC3422529</ArticleId><ArticleId IdType="pubmed">22700435</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Li L., Lin W.L., Dickson D.W., Petrucelli L., Zhang T., Wang X. The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons. Hum. Mol. Genet. 2013;22:4706&#x2013;4719. doi: 10.1093/hmg/ddt319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt319</ArticleId><ArticleId IdType="pmc">PMC3820133</ArticleId><ArticleId IdType="pubmed">23827948</ArticleId></ArticleIdList></Reference><Reference><Citation>Magrane J., Hervias I., Henning M.S., Damiano M., Kawamata H., Manfredi G. Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities. Hum. Mol. Genet. 2009;18:4552&#x2013;4564. doi: 10.1093/hmg/ddp421.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp421</ArticleId><ArticleId IdType="pmc">PMC2773270</ArticleId><ArticleId IdType="pubmed">19779023</ArticleId></ArticleIdList></Reference><Reference><Citation>Calkins M.J., Manczak M., Mao P., Shirendeb U., Reddy P.H. Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer&#x2019;s disease. Hum. Mol. Genet. 2011;20:4515&#x2013;4529. doi: 10.1093/hmg/ddr381.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr381</ArticleId><ArticleId IdType="pmc">PMC3209824</ArticleId><ArticleId IdType="pubmed">21873260</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal J., Kuang L., Barnett K.R., Zhu B.Z., Shissler S.C., Korotkov K.V., Hayward L.J., Kasarskis E.J., Zhu H. ALS mutant SOD1 interacts with G3BP1 and affects stress granule dynamics. Acta Neuropathol. 2016;132:563&#x2013;576. doi: 10.1007/s00401-016-1601-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1601-x</ArticleId><ArticleId IdType="pmc">PMC5023729</ArticleId><ArticleId IdType="pubmed">27481264</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinelli P., Belford M.E., Lennon N., Bacskai B.J., Hyman B.T., Trotti D., Brown R.H., Jr. Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron. 2004;43:19&#x2013;30. doi: 10.1016/j.neuron.2004.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.06.021</ArticleId><ArticleId IdType="pubmed">15233914</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong N.H., Tak Y.J., Rhim H., Kang S. Hip2 ubiquitin-conjugating enzyme has a role in UV-induced G1/S arrest and re-entry. Genet. Genom. 2019;41:159&#x2013;166. doi: 10.1007/s13258-018-0747-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13258-018-0747-4</ArticleId><ArticleId IdType="pubmed">30264212</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon E.J., Park H.J., Kim G.Y., Cho H.M., Choi J.H., Park H.Y., Jang J.Y., Rhim H.S., Kang S.M. Intracellular amyloid beta interacts with SOD1 and impairs the enzymatic activity of SOD1: Implications for the pathogenesis of amyotrophic lateral sclerosis. Exp. Mol. Med. 2009;41:611&#x2013;617. doi: 10.3858/emm.2009.41.9.067.</Citation><ArticleIdList><ArticleId IdType="doi">10.3858/emm.2009.41.9.067</ArticleId><ArticleId IdType="pmc">PMC2753654</ArticleId><ArticleId IdType="pubmed">19478559</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y., Park J.H., Jang J.Y., Rhim H., Kang S. Characterization and Hsp104-induced artificial clearance of familial ALS-related SOD1 aggregates. Biochem. Biophys. Res. Commun. 2013;434:521&#x2013;526. doi: 10.1016/j.bbrc.2013.03.107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2013.03.107</ArticleId><ArticleId IdType="pubmed">23583391</ArticleId></ArticleIdList></Reference><Reference><Citation>Park H.M., Kim G.Y., Nam M.K., Seong G.H., Han C., Chung K.C., Kang S., Rhim H. The serine protease HtrA2/Omi cleaves Parkin and irreversibly inactivates its E3 ubiquitin ligase activity. Biochem. Biophys. Res. Commun. 2009;387:537&#x2013;542. doi: 10.1016/j.bbrc.2009.07.079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2009.07.079</ArticleId><ArticleId IdType="pubmed">19631192</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang J.Y., Cho H., Park H.Y., Rhim H., Kang S. ALS-linked mutant SOD1 proteins promote A&#x3b2; aggregates in ALS through direct interaction with A&#x3b2;. Biochem. Biophys. Res. Commun. 2017;493:697&#x2013;707. doi: 10.1016/j.bbrc.2017.08.127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2017.08.127</ArticleId><ArticleId IdType="pubmed">28864422</ArticleId></ArticleIdList></Reference><Reference><Citation>Leyton-Jaimes M.F., Benaim C., Abu-Hamad S., Kahn J., Guetta A., Bucala R., Israelson A. Endogenous macrophage migration inhibitory factor reduces the accumulation and toxicity of misfolded SOD1 in a mouse model of ALS. Proc. Natl. Acad. Sci. USA. 2016;113:10198&#x2013;10203. doi: 10.1073/pnas.1604600113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1604600113</ArticleId><ArticleId IdType="pmc">PMC5018779</ArticleId><ArticleId IdType="pubmed">27551074</ArticleId></ArticleIdList></Reference><Reference><Citation>De Marco N., Buono M., Troise F., Diez-Roux G. Optineurin increases cell survival and translocates to the nucleus in a Rab8-dependent manner upon an apoptotic stimulus. J. Biol. Chem. 2006;281:16147&#x2013;16156. doi: 10.1074/jbc.M601467200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M601467200</ArticleId><ArticleId IdType="pubmed">16569640</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S.H. Ethyl acetate fraction of adenophora triphylla var. japonica inhibits migration of lewis lung carcinoma cells by suppressing macrophage polarization toward an M2 phenotype. J. Pharmacopunct. 2019;22:253&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6970570</ArticleId><ArticleId IdType="pubmed">31970023</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J.H., Park H.S., Hong S., Kang S. Motor neurons derived from ALS-related mouse iPS cells recapitulate pathological features of ALS. Exp. Mol. Med. 2016;48:e276. doi: 10.1038/emm.2016.113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emm.2016.113</ArticleId><ArticleId IdType="pmc">PMC5192071</ArticleId><ArticleId IdType="pubmed">27932790</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>